<unk>  is a antiviral drug that is FDA approved for the prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant (HSCT).   Common adverse reactions include nausea, diarrhea, vomiting, peripheral edema, cough, headache, fatigue, and abdominal pain.
Letermovir
Adefovir
Saquinavir
Fomivirsen
Entecavir
Lamivudine
Fosamprenavir
Abacavir